CN Bio
CN Bio develops organ-on-a-chip technologies that mimic human physiology for drug discovery and development. Their cutting-edge platforms accelerate the development of therapeutics by providing more accurate predictions of a drug's efficacy and toxicity earlier in the research process.Content by CN Bio
A turnkey solution for lab managers seeking reliable, human-relevant toxicology insights
| 1 min read
Streamlining drug development with a gut/liver-on-a-chip solution
Updated | 1 min read
System to be launched at Society of Toxicology’s 2021 Virtual Annual Meeting, March 12-26th, 2021
| 2 min read
The funding will be used to develop and test advanced cell culture models that represent different regions of the lung
| 2 min read
FDA publication demonstrates advantages of PhysioMimix in drug safety and metabolism applications over standard techniques
| 2 min read
Extended range of services supports accelerated drug discovery and development using predictive 3D Liver-on-Chip technology
| 2 min read
Page 1 of 1 - 6 Total Items
